Company data
Septerna Inc employees and revenue per employee
SEPN · Biotechnology · $1.73B market cap
Septerna Inc had 130 employees at the end of fiscal Dec 2025, up 73.3% from a year earlier. Revenue for the year was $46.0M, up 4174.5% from a year earlier, or $353K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
130
+73.3% YoY
Revenue
$46.0M
+4174.5% YoY
Revenue / employee
$353K
Peer median $459K
Rank in industry
69 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 130 | $46.0M | $353K | +73.3% | +4174.5% |
| Dec 2024 | 75 | $1.1M | $14K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Septerna Inc against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| FENC Fennec Pharmaceuticals Inc. | 35 | $44.6M | $1.28M | Hiring into decline |
| NKTR Nektar Therapeutics | 63 | $55.2M | $877K | Hiring into decline |
| TNGX Tango Therapeutics, Inc. | 137 | $62.4M | $455K | Leaner |
| SEPN Septerna Inc | 130 | $46.0M | $353K | Efficient growth |
| PTGX Protagonist Therapeutics, Inc. | 132 | $46.0M | $349K | Hiring into decline |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| KYMR Kymera Therapeutics, Inc. | 238 | $39.2M | $165K | Hiring into decline |
| OCUL Ocular Therapeutix, Inc. | 325 | $51.8M | $159K | Hiring into decline |
| AGIO Agios Pharmaceuticals, Inc. | 539 | $54.0M | $100K | Efficient growth |
Questions about Septerna Inc
- How many employees does Septerna Inc have?
- Septerna Inc reported 130 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 9, 2026. That is up 73.3% from a year earlier.
- What is Septerna Inc's revenue per employee?
- Septerna Inc brought in $46.0M of revenue in fiscal Dec 2025, which is $353K per employee. That ranks 69 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare SEPN with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Septerna Inc's annual reports (Form 10-K), latest filed March 9, 2026. This is data, not a recommendation to buy or sell SEPN.